供应商 · 服务 / 咨询 · 发现——同类成熟企业

Fermenta Biotech Limited

Fermenta Biotech Limited（FBL）成立于 1951 年，是全球最大的维生素 D3 制造商之一和重要的全球参与者：总部位于印度塔那，服务全球客户并拥有覆盖世界的分销网络；先进研发中心设在塔那，一流制造设施位于喜马偕尔邦库卢和古吉拉特邦达赫。除维生素 D3 外，FBL 还提供利基原料药（API）、抗生素合成用酶等一体化生物技术平台，以及废水管理与处理的环境方案。

运营中印度亚洲成立 1951 已上市员工: 600+ (human capital strength) 核实于 2026-10-05

简介

Fermenta Biotech Limited (FBL) is a global manufacturer of Vitamin D3, enzymes, and niche APIs, headquartered in Thane, India. Established in 1951, the company is publicly listed on the BSE. It operates state-of-the-art manufacturing facilities in Kullu, Dahej, and Tirupati, supported by an R&D center in Thane.

FBL remains active and reported FY26 consolidated revenue of approximately INR 528 crore. Key developments in 2025–2026 include the patenting and commercialization of plant-based Vitamin D3 (VITADEE Green) and the transfer of its Environment Division to a subsidiary.

Sources#

行业: 化妆品, 能源, 饲料, 渔业与水产养殖, 食品配料, 工业化学, 包装与塑料, 纺织与皮革, 兽医, 水务
主题: 维生素、类胡萝卜素与保健活性成分, 酶与生物催化
角色: 服务 / 咨询 — “…er treatment, EPC services, consultancy). - Backward integration to secure raw materials (e.g., cholesterol) f…”
为何属于生物经济: Fermenta Biotech Limited是一家历史悠久的印度上市生物技术/制造企业，生产维生素D3以及其他工业生物技术产品（酶和环保废水解决方案），业务从印度辐射全球。
发现途径: Enzymaster 酶赛生物; Zhejiang NHU Company; CJ CheilJedang (CJ Biomaterials); Advanced Enzyme Technologies (NSE)

供应的生物解决方案 0

尚未被列为已评级方案的供应商。

产品与服务

子公司: Fermenta Biotech USA LLC · Fermenta USA, LLC · Fermenta Biotech GmbH

新闻与状态 6

2026-08 最新状态: 2026年8月，公司股票在印度国家证券交易所（NSE）上市。 ↗ ↗ ↗
2026-09-09 Fermenta Biotech signs exclusive licence agreement with VIT Vellore for vitamin B12 fortification technology - Express Pharma
Fermenta Biotech Limited has signed an exclusive license with VIT Vellore to commercialize a natural in-situ Vitamin B12 fortification technology for fermented foods, leveraging VIT’s CBST research and Fermenta’s expertise in vitamins, premixes, and food …
2026-07-28 Fermenta Biotech expands plant-based Vitamin D3 capacity at Dahej plant | Industry News - Business Standard
Fermenta Biotech Limited is expanding its plant-based Vitamin D3 capacity at its Dahej facility, with a ₹110 crore capex to add about 1 tonne/year of plant-based D3, 50 kg/year of D3 derivatives, and 75 kilolitres of fermentation capacity, aiming to begin …
2026-08-04 Fermenta Biotech lists on NSE - The HinduBusinessLine
Fermenta Biotech Ltd listed its equity shares on the NSE, marking a milestone in its 75-year journey and broadening its investor base, while continuing to be listed on the BSE. The company, a major Vitamin D3 API producer with over 60 countries of customers, …
2026-10-05 Fermenta Opens Food Fortification Centre At NIFTEM-T
Fermenta Biotech Limited is expanding its role beyond manufacturing premium nutritional ingredients by partnering to establish the Fermenta – Centre of Excellence for Food Fortification at NIFTEM-T, a collaborative hub with MoFPI, NIFTEM-T, and GAIN to …
2026-10-05 Food Fortification Gets Dedicated Research Centre as Fermenta, NIFTEM T, MoFPI and GAIN Collaborate in Thanjavur - Prittle Prattle News
Fermenta Biotech Limited is a key partner in establishing the Fermenta Centre of Excellence for Food Fortification (CEFF) at NIFTEM Thanjavur, contributing its expertise in nutritional ingredients, premixes, and fortification to bridge lab research and …
2026-09-30 Fermenta Biotech promoter Preeti Thakkar sells 3.96% stake
Fermenta Biotech Limited saw its promoter Preeti Thakkar reduce her stake from 7.61% to 3.65% by selling 11,65,938 shares (3.96%) in open market on Sept 28, 2026. The company also rescheduled its one-to-one investor meeting to Oct 5, 2026 in Mumbai with no …

关系网络：股东、合作伙伴、同类

股权与投资方 4

投资方	DIL Limited
子公司	Fermenta Biotech USA LLC
子公司	Fermenta USA, LLC
子公司	Fermenta Biotech GmbH

身份与联系方式

联系方式、人员和法律信息仅向会员开放。

会员登录